Published in Psychopharmacology (Berl) on June 01, 1997
Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice. Mol Brain (2009) 1.37
Assessment of social interaction behaviors. J Vis Exp (2011) 1.09
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol (2000) 1.02
Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus. Psychopharmacology (Berl) (2007) 0.91
Blockade of phencyclidine-induced effects by a nitric oxide donor. Br J Pharmacol (2000) 0.86
From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berl) (2004) 0.85
Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide. Interdiscip Toxicol (2013) 0.82
Inhibition of neuronal nitric oxide reduces anxiety-like responses to pair housing. Behav Brain Res (2007) 0.80
Nitric Oxide Synthase Inhibitors as Antidepressants. Pharmaceuticals (Basel) (2010) 0.75
Chronic Nonmodulated Microwave Radiations in Mice Produce Anxiety-like and Depression-like Behaviours and Calcium- and NO-related Biochemical Changes in the Brain. Exp Neurobiol (2016) 0.75
(-)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats. Oxid Med Cell Longev (2016) 0.75
Hyperbaric oxygen treatment suppresses withdrawal signs in morphine-dependent mice. Brain Res (2016) 0.75
Effect of Vitamin E Administration on Learning of the Young Male Rats. J Exp Neurosci (2015) 0.75
An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test. Life Sci (2011) 0.75
Methylene blue and its analogues as antidepressant compounds. Metab Brain Dis (2017) 0.75
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl (2007) 2.12
Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav (2001) 1.81
Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav (2005) 1.70
Comparative liver toxicity of various erythromycin derivatives in animals. J Antimicrob Chemother (1988) 1.41
On the role of prolyl oligopeptidase in health and disease. Neuropeptides (2006) 1.39
Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother (1982) 1.32
Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav (2004) 1.32
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother (1983) 1.24
Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl) (1994) 1.12
Appropriate use of "knockout" mice as models of depression or models of testing the efficacy of antidepressants. Psychopharmacology (Berl) (2001) 1.12
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors. J Med Chem (1989) 1.12
Interpretation of knockout experiments: the congenic footprint. Genes Brain Behav (2007) 1.11
Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. Eur J Pharmacol (1988) 1.09
Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe? J Med Ethics (2010) 1.07
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev (1999) 1.04
Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) (1998) 1.04
A screen for genes induced in the amygdaloid area during cat odor exposure. Genes Brain Behav (2004) 1.01
Influence of age on behavioural response in the light/dark paradigm. Physiol Behav (1999) 0.98
Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes Immun (2005) 0.98
The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.98
Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse. Br J Anaesth (1976) 0.97
High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction. J Chromatogr B Biomed Sci Appl (2001) 0.97
Pharmacokinetics of nalidixinic acid and oxolinic acid in healthy women. Clin Pharmacol Ther (1976) 0.97
Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res (1997) 0.97
Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl (1995) 0.96
New selective COMT inhibitors: useful adjuncts for Parkinson's disease? Trends Pharmacol Sci (1989) 0.96
Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun (2004) 0.94
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur J Pharmacol (1997) 0.94
CCK in animal and human research on anxiety. Trends Pharmacol Sci (1993) 0.94
5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J Neurochem (2001) 0.94
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.94
Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology (Berl) (1999) 0.93
A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease. Br J Pharmacol (2012) 0.92
Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values. Med Hypotheses (2001) 0.91
Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state. J Antimicrob Chemother (1988) 0.91
Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology (2000) 0.91
General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. Gen Pharmacol (1994) 0.91
Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiol Genomics (2009) 0.91
Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. J Physiol Pharmacol (2003) 0.91
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner. Br J Pharmacol (2011) 0.91
The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol (1996) 0.90
Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol (2007) 0.90
The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa. Acta Neurol Scand (1985) 0.90
Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder. Transl Psychiatry (2012) 0.89
A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav (1998) 0.89
Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol (1984) 0.88
Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Eur J Pharmacol (1990) 0.88
Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci (1997) 0.88
Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat. J Neural Transm (1987) 0.88
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers. Clin Neuropharmacol (1995) 0.88
Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci (2000) 0.88
First report of mirtazapine-induced arthralgia. Eur Psychiatry (2001) 0.88
Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology (Berl) (2001) 0.87
IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun (2003) 0.87
Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav Brain Res (1990) 0.87
The value of the reserpine test in psychopharmacology. Arzneimittelforschung (1983) 0.87
[Arthralgia associated with mirtazapine]. Therapie (2001) 0.87
Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. Eur J Pharmacol (1999) 0.87
Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. J Neurochem (2003) 0.87
Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience (2008) 0.87
Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro. J Antimicrob Chemother (1988) 0.86
Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol (2003) 0.86
Differential expression and distinct DNA-binding specificity of ME1a and ME2 suggest a unique role during differentiation and neuronal plasticity. Brain Res Mol Brain Res (1995) 0.86
The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test. Pharmacol Biochem Behav (2000) 0.85
The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors. Behav Brain Res (2001) 0.85
The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam Clin Pharmacol (1996) 0.85
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers. Eur Neuropsychopharmacol (1991) 0.85
Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res (2006) 0.85
Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berl) (2001) 0.85
Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. J Psychopharmacol (1998) 0.85
Effects of methylmercaptoimidazole (MMI), propylthiouracil (PTU), potassium perchlorate (KClO4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat. Acta Endocrinol (Copenh) (1979) 0.84
Tumor-producing and skin-irritating activity of dithranol (anthralin) and its 10-acyl analogues in SENCAR mice. Carcinogenesis (1986) 0.84
Effects of systemic carbidopa on dopamine synthesis in rat hypothalamus and striatum. J Neural Transm Park Dis Dement Sect (1992) 0.84
Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Clin Exp Immunol (2011) 0.84
Tonsillar penetration of erythromycin and its 2'-acetyl ester in patients with chronic tonsillitis. J Antimicrob Chemother (1988) 0.84
Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol (1999) 0.83
Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur J Pharmacol (1991) 0.83
Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse. Psychopharmacology (Berl) (1991) 0.83
Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother (1985) 0.83
Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes Immun (2004) 0.83
BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Neuropeptides (1999) 0.83
Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatr Scand (1997) 0.83
Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur J Pharmacol (1993) 0.83
Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo. Neuroscience (2011) 0.83
Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers. Antimicrob Agents Chemother (1984) 0.83
Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study. Neuroscience (2008) 0.82
A typical mood stabilizers: a "typical role for atypical antipsychotics. Acta Psychiatr Scand Suppl (2005) 0.82
Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage. Placenta (2013) 0.82
Orphan receptor COUP-TF I antagonizes retinoic acid-induced neuronal differentiation. J Neurosci Res (1995) 0.82
Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.82
[Psychopharmacological profile of venlafaxine]. Encephale (1999) 0.82